August 1-2, 2012
ICare4Autism International Autism Conference
Autism: A Global Perspective
at the International Conference Center (ICC) in Jerusalem, Israel
Following the overwhelming success of the past conferences at the Albert Einstein College of Medicine in NYC in 2011 and in Jerusalem, Israel in 2010, ICare4Autism is once again bringing together top leading medical and educational professionals and researchers working in autism.
The purpose of the ICare4Autism conferences are to share current groundbreaking research into the causes and treatment of Autism Spectrum Disorders , and to be a catalyst for powerful interdisciplinary collaborations to tackle the global autism crisis.
Dame Stephanie Shirley, The British Government’s Founding Ambassador for Philanthropy, and Chairman of the Shirley Foundation, will deliver the Conference’s keynote address.
Dr. Joshua Weinstein, CEO & Founder of ICare4Autism explains, “We have entered a new age of autism, characterized on the one hand by unprecedented incidence, and on the other by advanced research, earlier diagnosis, and progressively more effective intervention. The evidence is clear- autism and hope are no longer mutually exclusive, but the need for action has never been more urgent.”
Dr. Eric Hollander, Chairman of the ICare4Autism Advisory Council said, “The ICare4Autism 2012 Global Conference will be a unique opportunity for leading researchers, clinicians, educators and policymakers from all over the world to share their latest findings and create powerful new international collaborations that will ultimately allow us to discover the etiology of autism and its biologic and environmental causes. This global cross-disciplinary gathering will play a vital role in speeding the development of improved methods of autism detection and treatment that are urgently needed by patients and the families.”
Partial list of speakers
Dame Stephanie Shirley, The British Government’s Founding Ambassador for Philanthropy, and Chairman of the Shirley Foundation, will deliver the Conference’s keynote address.
Dr. Joshua Weinstein, Founder & CEO of ICare4Autism, Shema Kolainu – Hear Our Voices, School and Center for Children with Autism and TISHMA, ABA Center for Children with Autism, USA and Israel
Dr. Eric Hollander, Director of the Autism Spectrum Program at Albert Einstein College of Medicine/Montefiore Medical Center and Chairman of the ICare4Autism Advisory Council, USA
Dr. Eli Hatchwell, Chief Scientific Officer, Population Diagnostics UK, Inc.
Dr. Carlos Marcin Salazar, Director, The National Autism Clinic of Mexico (Clima)
“ASD and advocacy”
Eitan Eldar, Ph.D., BCBA-D, Chairman of the Israeli Association of Applied Behavior Analysis, Founder and Director of the Applied Behavior Analysis Center (Teaching, Community Services & Research) at the Zinman College in Israel
Brett Abrahams, PhD, Assistant Professor, Departments of Genetics & Neuroscience at Einstein, USA
“The Autism Spectrum Disorders: from Genes to Function”
Dr. S. Mariam Aljunied, Lead Specialist for Educational Psychology, Singapore Ministry of Education, Singapore
“Right-siting children with autism: a global search for the ‘right’ solution”
Dr. Lorene Amet DEA, DipBiotechnol, D Phil, MEd (Autism), Principal Scientist Autism Treatment Trust, Scotland
“The biology of Autism Syndromes: from diagnosis to intervention”
Merry Barua, Director Action For Autism – National Centre for Autism, India
Sami Basha, PhD, President Assistant for Quality and Scientific Research, Prof. of Special Education, Palestine Ahliya University
Agatino Battaglia, M.D., DPed, DNeurol, Professor of Child Neuropsychiatry at the Post-Graduate Medical School in Child Neuropsychiatry, at the University of Pisa, Italy
“Etiological heterogeneity of autism spectrum disorders”
Nirit Bauminger, PhD., Associate Professor, Head, Graduate Program in Special Education, Specializing in ASD, School of Education, with Dr. Yael Kimhi, Dr. Dana Shoam Kugelmas, and Dr. Galit Agam Ben Artzi, Bar – Ilan University, Israel “Social cognition, social emotions and social relationship in preschoolers with HFASD–new findings and intervention implication”
Juan Carlos Brandt, Chief, Advocacy and Special Events, Department of Public Information, United Nations
W. Ted Brown, M.D., Ph.D., Director, NYS Institute for Basic Research in Developmental Disabilities, USA
“The Fragile X Syndrome and Autism”
Henry Butt MSc Ph.D., Bioscreen Specialist Medical Testing Laboratories, Australia
“The changes of the intestinal microbial flora of patients with autism”
Robert Didden, Ph.D., Professor at Radboud University, Nijmegen, The Netherlands
“Effectiveness of low intensity behavioral treatment (ABA) in young children with ASD and intellectual disability: Results of a Dutch RCT study and variables predicting treatment success”
Eynat Gal, Ph.D., Prof. Patrice L. (Tamar) Weiss, Dept. of Occupational Therapy, University of Haifa, Israel; Dr. Sigal Eden and Nirit Bauminger, PhD., Associate Professor, Head, Graduate Program in Special Education, Specializing in ASD, School of Education, Bar – Ilan University, Israel, and Dr. Massimo Zancanaro, Italy
“Participatory Design of Technology to Create Intervention Tools for Children with ASD”
Randi J. Hagerman, M.D., F.A.A.P. Medical Director, UC Davis M.I.N.D. Institute, USA
“New Initiatives in Autism Research and Practice”
Hakon Hakonarson, MD, PhD, Center for Autism Research, The Joseph Stokes Jr. Research Institute, The Children’s Hospital of Philadelphia, PA, USA
“Gene networks underlying autism targeted for therapeutic intervention”
Martha R. Herbert, M.D.,Ph.D., Assistant Professor of Neurology at Harvard Medical School, Pediatric Neurologist at the Massachusetts General Hospital in Boston, Director of the TRANSCEND Research Program (Treatment Research and Neuroscience Evaluation of Neurodevelopmental Disorders), USA
“Transending Autism: A whole-body systems and gene-environment approach”
Eileen Hopkins, International Development Director for Autistica and Member of the World Health Organization’s Expert Group on Autism
Mady Hornig, MA, MD, Director of Translational Research, Center for Infection and Immunity, Associate Professor of Epidemiology, Mailman School of Public Health, Columbia University, USA
“Biologic mechanisms in autism”
José Humberto Nicolini-Sánchez, M.D., Ph.D., Professor, Universidad de la Ciudad de Mexico & Director, Carraci Medical Group, Mexico
“Genetic basis of compulsive behaviors in ASD”
Dov Inbar, M.D., Visiting Assistant Professor of Pediatrics. CERC. Albert Einstein School of Medicine. Yeshiva University, New York; Senior Lecturer of Pediatrics. Sackler Faculty of Medicine. Tel Aviv University; Head, The Child Development Department. Schneider Children’s Medical Center, Israel
Jeongil Kim, Ph.D. Director, Lotus Flowers Children Center, Chief Executive, Play Therapy Korea, Dean of International Affairs, Daegu Cyber University, Korea
“Art-based Transition Program to Adulthood for Children with ASD”
Hugh Morgan, CEO of Autism Wales & Expert Advisor for ASD to the Welsh Assembly Government, Wales, UK
James W. Partington, Ph.D., BCBA-D, Director, Behavior Analysts, Inc., USA
“Teach your children well: Practical advice for parents and professionals regarding designing and implementing effective interventions for the acquisition of language and social interaction skills”
Dr. Alexis L. Reyes, Associate Professor, Developmental and Behavioral Studies Unit, Department of Pediatrics, Philippine General Hospital, Philippines
Harry D Schneider, PhD, MD, PC, The Center for Medical & Brain Sciences, The Autism Family International Foundation, USA
“Minimally-verbal Children with Autism: The use of functional MRI (FMRI) to demonstrate dysfunctional language networks and Transcranial Direct Current Stimulation (TDCS) to restore functional language in these children.”
Stephen Shore, Ed.D., Assistant Professor, Special Education at Adelphi University, Author, Beyond the Wall: Personal Experiences with Autism and Asperger Syndrome “Life on and Slightly to the Right of the Autism Spectrum: In Inside View Towards Success”
Dr. Mike Snape, Chief Scientific Officer at Autism Therapeutics Ltd, UK
“NNZ-2566: Rationale for use in Autism Spectrum Disorders”
Helen Tager-Flusberg, PhD, Professor, Department of Psychology, Boston University, Professor, Departments of Anatomy & Neurobiology and Pediatrics, BUSM, President, International Society for Autism Research, USA
“Early risk signs and development of language in autism spectrum disorder”
Abbie Weisberg, CEO/Executive Director, Keshet, USA
Pamela Wolfberg, Ph.D., Autism Spectrum Program-Department of Special Education, San Francisco State University, USA
“Integrated Play Groups®: Guiding Children with Autism in Social and Imaginary Worlds with Typical Peers”
Lonnie Zwaigenbaum, M.D. Stollery Children’s Hospital Foundation Endowed Chair in Autism Research; Developmental Pediatrician and Associate Professor of Pediatrics, University of Alberta, Canada
“Advances in Early Detection and Diagnosis of Autism”
Additional speakers will be announced later this year.
If you would like the opportunity to report on empirical research or pilot projects for future research, please find more information about our Poster Presentation Format and Submission Process here.
Sponsored by
ICare4Autism
International Center for Autism Research & Education
1515 Broadway, 11th floor
New York, New York 10036
Phone: 212.537.9087
Toll Free: 877.226.4440
Fax: 646.417.7477
info@icare4autism.org
